Companies/CA/RKV

RAKOVINA THERAPEUTICS INC.

Last · TSXVC$0.220.00 (0.00%)close · yahoo · 22h ago
Vol 590 ≈ 130
Market capC$5.4M24.4M sh
P/E · TTM-0.8fwd — · eps -0.31 · loss
Beta-0.24vs S&P 500
Div yield0.00%annual · TTM
52w range
C$0.085C$0.32
Volume590session

Issuer

Legal nameRAKOVINA THERAPEUTICS INC.
HQCanada (CA)
ListingCA RKV
ISINCA75103L3092
LEI254900O0YVEUNI9UM016
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyCAD
Entity registrytsx:RKV
Org IDRKV
Websitewww.rakovinatherapeutics.com
LinkedIn
AddressRakovina Therapeutics, Inc. 999 West Broadway V5Z 1K5, Vancouver
Loading chart…

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
View upcoming earnings →

Press & signals

3 of 7 recent
  • GlobeNewswire

    Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development

  • GlobeNewswire

    Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member

  • GlobeNewswire

    Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans